Barclays Starts Karyopharm Therapeutics (KPTI) at Overweight

March 4, 2020 4:41 AM

Barclays analyst Peter Lawson initiates coverage on Karyopharm Therapeutics (NASDAQ: KPTI) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found